Re: Merck lands positive PhIII for its CETP drug anacetrapib

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

bfw

Rank: Vice President [?]

Points: 840 [?]

Votes: 19 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Merck lands positive PhIII for its CETP drug anacetrapib

in response to

Re: Merck lands positive PhIII for its CETP drug anacetrapib

bfw

posted on Jun 27, 2017 10:06AM

This "may" help RVX.

HDL as a target is now back in play for residual risk.

ILb data showed inflammation is in play.

LDL hypothesis subscribers can't really deny the evidence that other targets are useful.

Ideally, the anacetrapib results will be enough to draw attention back to the space but not significant enough for Merck to move forward with the drug.